AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Emergent BioSolutions Inc. Director's Dealing 2010

Jul 30, 2010

32870_dirs_2010-07-30_26ae1ffb-3d83-4e9d-b991-2220778c00a2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2010-07-28

Reporting Person: Abdun-Nabi Daniel (Director, President & COO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-07-28	Common Stock	S	7950	$18.92	Disposed	34345	Direct
2010-07-29	Common Stock	S	10200	$18.65	Disposed	24145	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi. Mr. Abdun-nabi's direct holdings include restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan that vest in three equal installments beginning March 9, 2011.